Wednesday, 12 Dec 2018

You are here

RheumNow Week in Review – 21 October 2016

Dr. Cush Reviews Highlights from the past week on Register to receive free daily rheumatology news written by rheumatologists for rheumatologists. Download the podcast at

  1. The Japanese SURPRISE study looked 223 RA MTX-IR patients Rx with either TCZ+MTX or TCZ: earlier DAS28 Responses & less Xray damage seen with add-on vs switch therapy.
  2. Psoriasis patients failing TNF inhibitor shows secondary failure more likely than primary failure to respond to a 2nd TNFi.
  3. UK prevalence study shows only one-third of ankylosing spondylitis is treated by rheumatologists.
  4. 2 studies of 169 RA patients shows that US guided Bx for synovial tissue shown to be 82-93% success and with very rare AE (ie, hemarthrosis)
  5. Study of 104 early spondyloarthritis pts shows SI xrays readings maybe unreliable, even with experienced radiologists
  6. Postural abnormalities and worse spinal metrics in Ankylosing spondylitis is associated with significant balance issues.
  7. Surgical patients with Sleep Apnea at higher risk of atrial fibrillation and venous thromboembolism (preliminary results)
  8. Pregabalin/Lyrica shown to be effective in treating abdominal pain associated with irritable bowel syndrome.
  9. TNF inhibitor use in 16 renal transplant patients with good efficacy, no decline in GFR after 2yrs of followup, but 50% had Serious infections,
  10. Just presented: the Nor-Switch Study shows it's safe to switch to a biosimilar
  11. Inflectra Biosimilar estimated to ship in Late November 2016 
  12. Low-Molecular Weight Heparin Does Not Reduce Pregnancy Complications
  13. Review of Herpes Zoster with Immunosuppression and Autoimmune Disease
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – Can RA Be Prevented (12.7.18)

Dr. Jack Cush reviews the news and new journal articles from the past week on

Chronic Kidney Disease Increasing in the U.S.A.

JAMA has published the Global Burden of Disease (GBD) study showing that that, from 2002 to 2016, the US burden of chronic kidney disease (CKD) increased, with some states exhibiting more than twice the burden as others. The increase in burden was associated with increased metabolic and dietary risk exposure that manifested in increased probability of death due to diabetic CKD, especially for those between 20 to 55 years.  

RheumNow Podcast – To Needle or Not to Needle (11.30.18)

Dr. Jack Cush updates the news and reports from the past week at

Physical Activity Guidelines for Americans

The data are clear and disappointing: despite the well-known health benefits, four out of five US adults are not active physically.  JAMA has published the new US Physical Activity Guidelines for Americans, so that health professionals and policy makers can promote lifestyle changes and awareness of the the health benefits of physical activity.

The RheumNow Podcast – Heartbreak of Methotrexate (11.16.18)

Dr. Jack Cush reviews the news from the past week at